Showing 2801-2810 of 5909 results for "".
- CooperVision Biofinity Toric Multifocal Contact Lenses Now Available Nationwide in the UShttps://modernod.com/news/coopervision-biofinity-toric-multifocal-contact-lenses-now-available-nationwide-in-the-us/2477786/CooperVision has announced that its new Biofinity toric multifocal contact lenses are now available nationwide in the United States. “Amid the COVID-19 pandemic, we understand that eye care practices are operating under various circumstances, and for many, fitting contact lenses still may
- EyePoint Pharmaceuticals Presents Data Showcasing Dexycu at the ASCRS Virtual Meetinghttps://modernod.com/news/eyepoint-pharmaceuticals-presents-data-showcasing-dexycu-at-the-ascrs-virtual-meeting/2477784/EyePoint Pharmaceuticals announced the presentation of positive retrospective case study data supporting Dexycu (dexamethasone intraocular suspension) 9% for the treatment of postoperative inflammation following ocular surgery. The data were presented in three electronic posters and one oral pape
- VSY Biotechnology Says It Has Developed a New Drug to Treat COVID-19https://modernod.com/news/vsy-biotechnology-says-it-has-developed-a-new-drug-to-treat-covid-19/2477774/Ophthalmic company VSY Biotechnology announced that its research center has developed a new drug, TR-C 19, to treat COVID-19. Studies have shown that TR-C 19 can neutralize the virus isolated under laboratory conditions, according to a company news release. The drug is now at the authority
- Artificial Intelligence Algorithm Can Rapidly Detect Severity of Common Blinding Eye Diseasehttps://modernod.com/news/artificial-intelligence-algorithm-can-rapidly-detect-severity-of-common-blinding-eye-disease/2477752/A new artificial intelligence (AI) algorithm developed by researchers at New York Eye and Ear Infirmary of Mount Sinai (NYEE) can rapidly and accurately detect age-related macular degeneration (AMD), according to a company news release. The study, published in the April/May issue of Tr
- VisionCare Announces CE Mark Approval of the Tsert-SI Delivery System for the CentraSight Treatment Programhttps://modernod.com/news/visioncare-announces-ce-mark-approval-of-the-tsert-si-delivery-system-for-the-centrasight-treatment-program/2477744/VisionCare has received CE Mark for the Tsert-SI delivery system for the CentraSight treatment program, which includes the Implantable Miniature Telescope (by Dr. Isaac Lipshitz). The Tsert-SI delivery system includes a pre-loaded telescope implant injector, which only requires a 6.5mm incision,
- Dyno Therapeutics Collaborates With Novartis to Develop Improved Gene Therapies With AAV Vectors Based on AI Technologyhttps://modernod.com/news/dyno-therapeutics-collaborates-with-novartis-to-develop-improved-gene-therapies-with-aav-vectors-based-on-ai-technology/2477740/Dyno Therapeutics announced a collaboration with Novartis to develop improved adeno-associated virus (AAV) vectors for research, development, and commercialization of gene therapies for ocular diseases. Financial terms of the deal were not disclosed. The partnership will allow the p
- 1-800 Contacts Launches Online Glasses Lens Replacement Brand, Boomerang Lenseshttps://modernod.com/news/covid-19-weekly-review/2477734/1-800 Contacts unveiled Boomerang, an online lens replacement service that provides new lenses for consumers to put in their current glasses without having to visit an eye doctor or optical shop. As the current health crisis began to unfold, and eyecare providers and optical shops began f
- Visual Impairment Tied to Increased Dementia Risk in Older Womenhttps://modernod.com/news/visual-impairment-tied-to-increased-dementia-risk-in-older-women/2477730/Older women with objective visual impairment are likely to develop dementia or mild cognitive impairment, a secondary analysis of data from the Women’s Health Initiative (WHI) suggests, according to a Reuters report. Researche
- AbbVie, Allergan Gain US Antitrust Clearance for Dealhttps://modernod.com/news/abbvie-allergan-gain-us-antitrust-clearance-for-deal/2477714/The US Federal Trade Commission (FTC) accepted the proposed consent order in connection with AbbVie’s pending $63-billion acquisition of Allergan, the companies announced. The FTC’s decision means that all required antitrust clearances needed for the merger have now been obtained.
- AI-Supported Test Can Detect Glaucoma Progression 18 Months Earlierhttps://modernod.com/news/ai-supported-test-can-detect-glaucoma-progression-18-months-earlier/2477706/A new test can detect glaucoma progression 18 months earlier than the current gold standard method, according to results from a clinical trial sponsored by the University College London (UCL). The technology, supported by an artificial intelligence (AI) algorithm, could help accelerate cli